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Abstract We focus on the recent evidence that
elucidates our understanding about the effects of
cadmium (Cd) on human health and their prevention.
Recently, there has been substantial progress in the
exploration of the shape of the Cd concentration-
response function on osteoporosis and mortality.
Environmental exposure to Cd increases total mor-
tality in a continuous fashion without evidence of a
threshold, independently of kidney function and other
classical factors associated with mortality including
age, gender, smoking and social economic status.
Pooled hazard rates of two recent environmental
population based cohort studies revealed that for each
doubling of urinary Cd concentration, the relative risk
for mortality increases with 17% (95% CI 4.2–33.1%;
P\ 0.0001). Tubular kidney damage starts at urinary
Cd concentrations ranging between 0.5 and 2 lg
urinary Cd/g creatinine, and recent studies focusing
on bone effects show increased risk of osteoporosis
even at urinary Cd below 1 lg Cd/g creatinine. The
non-smoking adult population has urinary Cd con-
centrations close to or higher than 0.5 lg Cd/g
creatinine. To diminish the transfer of Cd from soil to
plants for human consumption, the bioavailability of
soil Cd for the plants should be reduced (external
bioavailability) by maintaining agricultural and gar-
den soils pH close to neutral (pH-H2O of 7.5; pH-
KCL of 6.5). Reducing the systemic bioavailability of
intestinal Cd can be best achieved by preserving a
balanced iron status. The latter might especially be
relevant in groups with a lower intake of iron, such as
vegetarians, and women in reproductive phase of life.
In exposed populations, house dust loaded with Cd is
an additional relevant exposure route. In view of the
insidious etiology of health effects associated with
low dose exposure to Cd and the current European Cd
intake which is close to the tolerable weekly intake,
one should not underestimate the importance of the
recent epidemiological evidence on Cd toxicity as to
its medical and public health implications.
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Introduction
Cadmium (Cd) is an ever-present and global envi-
ronmental pollutant. During the twentieth century,
the Cd concentration in human bones rose 10-fold in
France (Jaworowski et al. 1985). Populations world-
wide have a low-level intake through their food,
causing an age-related cumulative increase in the
body burden of this toxic metal (Ja¨rup et al. 1998c).
Environmental exposure levels to Cd, that are
substantially above the background, occur in areas
with current or historical industrial contamination for
instance in regions of Belgium, Sweden, UK, Japan,
and China.
We review the most substantial lines of research
that recently (since 1999) have been pursued and
elucidate our understanding about human health
effects of Cd at the population level. Hence, we
describe possible strategies of prevention for popu-
lations at risk.
External and internal exposure to Cd
Exposure to Cd occurs through intake of contami-
nated food or water, or by inhalation of polluted air.
Occupational exposures are found in industries such
as electroplating, welding, smelting and refining,
pigment production, and battery manufacturing.
Other respiratory exposure to Cd can occur through
inhalation of cigarette smoke (Ja¨rup et al. 1998c) or
indoor dust contaminated with Cd (Hogervorst et al.
2007).
In the non-anthropogenic influenced environment,
Cd concentration is generally low and is no related
with the concentration of other elements except zinc.
Daily human intakes are from 10 lg Cd/kg body
weight (humans exposed to high Cd concentrations)
to 0.1 lg/kg b.w. (Ja¨rup et al. 1998c). In order to
keep the urinary Cd concentration below 1 lg Cd/g
creatinine in 95% of the population by age of
50 years, a weekly dietary Cd exposure should stay
below 2.5 lg Cd kg body-weight (CONTAM 2009).
The average dietary intake of Cd in adults across
European countries was estimated to be between 1.9
and 3.0 lg/kg b.w. per week, and the highly exposed
adults have estimates in the range of 2.5–3.9 lg/kg
b.w. per week (CONTAM 2009). The CONTAM
Panel noted that such average dietary intake in
European countries is close to or slightly exceeding
the threshold of 2.5 lg/kg b.w. (CONTAM 2009).
Furthermore, it was noticed that subgroups of the
population, such as vegetarians, women in reproduc-
tive phase of life, smokers and people living in highly
contaminated areas may exceed the tolerably weekly
intake by about 2-fold.
Cd inhalation is a far smaller contributor to total
Cd body burden except in some industrial settings,
smokers or highly environmentally exposed subjects.
Smokers absorb amounts of Cd comparable to those
from food, about 1–3 lg of Cd per day. It has been
reported that one cigarette contains about 1–2 lg of
Cd and that about 10% of the Cd content is inhaled
when the cigarette is smoked (Nordberg et al. 2007).
A logic preventive measure is to stop smoking and to
avoid passive exposure to tobacco smoke (Bolte et al.
2008). Recent data show low Cd concentrations
(\5 ng Cd/m3) in the air of most European cities
(Nawrot et al. 2009), however, close to some
metallurgic plants values exceeding the WHO limit
value (5 ng Cd/m3) are still reported (e.g. measuring
station 0BE01, Beerse, Belgium, 27 ng Cd/m3;
http://www.vmm.be, accessed on November, 2009).
Belgium is no exception, and similar levels of envi-
ronmental exposure likely persist in the United States
and other European countries close to non-ferrous
sites.
Soil polluted with Cd, can be taken up by the wind
and thereby generating polluted dust particles. The
particles that contain Cd are generally bigger than
10 lm. They are too large to reach the lung alveoli,
but they will end up in the gastrointestinal tract by
mucociliary clearance from the naso-pharynx and
bronchi (Alfaro-Moreno et al. 2007). One can prevent
this way of Cd exposure by installing a well-closed
cover of plants on the contaminated soils. House dust
historically enriched by Cd is a relevant route of
exposure in polluted areas (Hogervorst et al. 2007). In
a population living in the vicinity of zinc refiners, a 2-
fold increase in the metal loading rate in house dust
was associated with increases in blood Cd (?2.3%)
and urinary Cd (?3.0%), independent of the intake of
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123
locally grown vegetables (Hogervorst et al. 2007).
Gastrointestinal absorption of Cd is estimated to be
around 5–8%, but may increase in cases of iron
deficiency (Flanagan et al. 1978). Inhalation absorp-
tion of Cd is generally higher than gastrointestinal
absorption. It ranges 10–50%, however, the absorp-
tion of Cd from cigarette smoke is between 25 and
50% (Nordberg et al. 2007).
Once absorbed, Cd binds avidly to metallothio-
nein. Cd is stored mainly in the kidneys and the liver,
and also in testes. The half-life in the body is
10–30 years. In general, nonsmokers have urinary Cd
concentrations of 0.02–0.7 lg/g creatinine, which
increase with age in parallel with the accumulation of
Cd in the kidney (Ja¨rup et al. 1998c; Staessen et al.
2001).
Urinary excretion of Cd is a biomarker of lifetime
Cd exposure. Cd excretion in 24-h urine is rather
stable in solute composition and is therefore the gold
standard to measure Cd in the urinary matrix.
However, a lower participation rate and/or incom-
plete sampling together with practical reasons might
incite to choose for spot urine. As spot urine samples
vary in dilution of the solute within individuals, often
urinary analytes are standardized to 1 g of creatinine.
However, creatinine might be influenced by muscle
mass, physical exercise, and the dietary intake of
proteins. The mean urinary Cd level in the US
population averaged 0.18 lg/g creatinine (95th per-
centile: 0.79 lg/g creatinine) (CDC 2005). In the
Belgian population urinary Cd averaged 0.80 lg/g
creatinine to 1.00 lg/g creatinine for those in the
vicinity of zinc smelters (Nawrot et al. 2008).
Japanese women living in non-polluted areas had
urinary Cd concentrations that were considerably
higher and ranged from 0.25 to 11.4 lg/g creatinine
(with a geometric mean of 2.87 lg/g creatinine)
(Ezaki et al. 2003). Recent biomonitoring in a
population living close to mining sites of Katanga
(Congo) revealed urinary Cd values of 0.75 lg/g
creatinine (Banza et al. 2009).
The Cd level in blood mainly reflects the last few
months of exposure. Differences in hematocrit levels
may cause some variability of the Cd concentration in
whole blood. Hematocrit levels in women range
normally from 35 to 47% and for men from 39 to
50%. To control for this variability, whole blood Cd
may be standardized for hematocrit. Non-smoking
adults living in non-polluted areas have blood Cd
concentrations that vary between 0.1 and 1.0 lg Cd/l
in whole blood.
Cd related morbidity
Osteoporosis
Osteoporosis is usually an age-related bone disorder.
Evidence accumulates that besides kidney the bone
is a primary target organ of Cd toxicity as well.
Clinical features associated with osteoporosis include
increased morbidity (pain, physical impairment,
decreased quality of life), increased risk of new
fractures and increased mortality (Van der Klift et al.
2002). Studies among populations from Belgium
(Staessen et al. 1999; Schutte et al. 2008b), Sweden
(Ja¨rup et al. 1998a; Alfve´n et al. 2000; A˚kesson et al.
2006), Japan (Honda et al. 2003) and China (Zhu
et al. 2004; Jin et al. 2004; Wang et al. 2003) showed
associations between osteoporosis and low-level
environmental Cd exposure. The generally accepted
interpretation has been that Cd-induced renal tubular
damage (Staessen et al. 1994) decreases the calcium
reabsorption in the nephron, resulting in hypercalci-
uria and decreased bone mineral density, and hence
increased fracture risk (Ja¨rup et al. 1998c; Staessen
et al. 1994) particularly in postmenopausal women
(Schutte et al. 2008b; Staessen et al. 1999) or men in
the older age group (Ja¨rup and Alfve´n 2004).
However, a recent study also found a dose–response
association between odds of osteoporosis in young
men (mean age 45) and urinary Cd (Nawrot et al.
2010). A selection of recent studies focusing on the
association between Cd exposure and bone effects is
given in Table 1.
A striking observation, considering the first epi-
demiological argument of Cd-induced bone effects,
was the clear-cut interference of low-level Cd
exposure with calcium metabolism. The Belgian
Cadmibel study showed for a 2-fold increase in the
urinary Cd excretion that the urinary calcium excre-
tion rose on average by 0.25 mmol/24 h (Buchet
et al. 1990). Hypercalciuria should be considered an
early tubulotoxic effect, because it may exacerbate
the development of osteoporosis, especially in the
elderly. Some years later, mineral density and
fracture incidence were assessed in 506 participants
of the initial population cohort (Staessen et al. 1999).
Biometals (2010) 23:769–782 771
123
T
a
b
le
1
S
el
ec
te
d
st
u
d
ie
s
o
n
b
o
n
e
d
en
si
ty
an
d
o
st
eo
p
o
ro
si
s
in
as
so
ci
at
io
n
w
it
h
ca
d
m
iu
m
ex
p
o
su
re
R
ef
er
en
ce
P
o
p
u
la
ti
o
n
E
ff
ec
t
m
ea
su
re
E
ff
ec
t
si
ze
M
ea
n
ex
p
o
su
re
/o
b
se
rv
ed
th
re
sh
o
ld
S
ta
es
se
n
et
al
.
(1
9
9
9
)
G
en
er
al
p
o
p
u
la
ti
o
n
,
n
=
5
0
6
.
P
ro
sp
ec
ti
v
e
st
u
d
y
,
m
ed
ia
n
fo
ll
o
w
-u
p
6
.6
y
ea
rs
,
B
el
g
iu
m
F
ra
ct
u
re
s/
b
o
n
e
d
en
si
ty
E
ac
h
d
o
u
b
li
n
g
in
U
C
d
as
so
ci
at
ed
w
it
h
1
.7
3
ti
m
es
h
ig
h
er
ri
sk
o
f
fr
ac
tu
re
in
w
o
m
en
(i
n
te
ra
ct
io
n
w
it
h
p
o
st
m
en
o
p
au
sa
l
st
at
u
s)
G
eo
m
et
ri
c
m
ea
n
U
C
d
co
n
ce
n
tr
at
io
n
:
8
.6
n
m
o
l/
d
ay
T
h
re
sh
o
ld
:
*
1
lg
C
d
/g
cr
t
W
an
g
et
al
.
(2
0
0
3
)
G
en
er
al
p
o
p
u
la
ti
o
n
(n
=
7
9
0
),
C
h
in
a
O
st
eo
p
o
ro
si
s
(T
-s
co
re
\
-
2
.5
)
O
d
d
s:
2
.0
9
(9
5
%
C
I
1
.0
8
–
4
.0
3
)
fo
r
th
e
h
ig
h
ly
p
o
ll
u
te
d
ar
ea
v
er
su
s
co
n
tr
o
l
ar
ea
U
C
d
2
.3
–
1
3
lg
C
d
/g
cr
t
(c
o
n
tr
o
l
v
s.
p
o
ll
u
te
d
ar
ea
)
A
lf
v
e´n
et
al
.
(2
0
0
4
)
G
en
er
al
p
o
p
u
la
ti
o
n
n
=
1
,0
2
1
.
R
et
ro
sp
ec
ti
v
e
st
u
d
y
,
S
w
ed
en
F
ra
ct
u
re
s
E
ac
h
l
g
U
C
d
/g
cr
t
1
8
%
(9
5
%
C
I
1
.0
–
3
8
%
)
h
ig
h
er
ri
sk
H
az
ar
d
ra
ti
o
re
ac
h
ed
3
.5
(9
0
%
C
I
1
.1
–
1
1
)
in
th
e
g
ro
u
p
o
f
su
b
je
ct
s
w
it
h
U
C
d
b
et
w
ee
n
2
an
d
4
l
g
/g
cr
t
co
m
p
ar
ed
w
it
h
\
0
.5
l
g
U
C
d
/g
cr
t.
A
v
er
ag
e
ex
p
o
su
re
0
.7
4
l
g
U
C
d
/g
cr
t
S
ig
n
ifi
ca
n
t
ef
fe
ct
s
o
b
se
rv
ed
fr
o
m
2
lg
U
C
d
/g
cr
t
Ji
n
et
al
.
(2
0
0
4
)
G
en
er
al
p
o
p
u
la
ti
o
n
(n
=
7
9
0
),
C
h
in
a
O
st
eo
p
o
ro
si
s
(Z
-S
co
re
\
-
2
)
P
re
v
al
en
ce
o
f
o
es
te
o
p
o
ro
si
s:
B
2
lg
U
C
d
/g
cr
t:
2
.4
%
(l
o
w
es
t
g
ro
u
p
),
5
l
g
U
C
d
/g
cr
t:
2
.5
%
,
1
0
lg
U
C
d
/g
cr
t:
6
%
,
2
0
lg
U
C
d
/g
cr
t:
1
4
.8
%
[
2
lg
C
d
/g
cr
t
K
id
n
ey
d
am
ag
e
o
b
se
rv
ed
A˚
k
es
so
n
et
al
.
(2
0
0
6
)
G
en
er
al
p
o
p
u
la
ti
o
n
(n
=
8
2
0
),
w
o
m
en
,
S
w
ed
en
B
o
n
e-
m
in
er
al
d
en
si
ty
(B
M
D
)
U
ri
n
ar
y
d
eo
x
y
p
y
ri
d
in
o
li
n
e
(U
D
P
)
B
M
D
:
-
0
.0
1
1
g
/c
m
2
/l
g
C
d
/l
U
D
P
:
1
6
n
m
o
l/
l/
lg
C
d
/l
M
ed
ia
n
U
C
d
:
0
.6
7
lg
/g
cr
t
S
tr
o
n
g
er
as
so
ci
at
io
n
s
in
p
o
st
-
m
en
o
p
au
sa
l
w
o
m
en
G
al
la
g
h
er
et
al
.
(2
0
0
8
)
G
en
er
al
p
o
p
u
la
ti
o
n
.
N
H
A
N
E
S
(n
=
4
,2
5
7
).
U
S
w
o
m
en
5
0
–
9
0
y
ea
r
o
f
ag
e
O
st
eo
p
o
ro
si
s
(T
-s
co
re
\
-
2
.5
)*
b
as
ed
o
n
H
ip
b
o
n
e
m
ea
su
re
m
en
ts
1
5
%
in
cr
ea
se
in
p
re
v
al
en
ce
o
f
o
st
eo
p
o
ro
si
s
p
er
1
l
g
C
d
/g
cr
t
in
u
ri
n
e
S
ig
n
ifi
ca
n
t
as
so
ci
at
io
n
s
at
U
C
d
le
v
el
s
\
1
lg
/g
cr
t
S
ch
u
tt
e
et
al
.
(2
0
0
8
a,
b
)
G
en
er
al
p
o
p
u
la
ti
o
n
.
(n
=
2
9
4
)
w
o
m
en
,
B
el
g
iu
m
.
P
ro
sp
ec
ti
v
e
co
h
o
rt
E
ff
ec
ts
in
d
ep
en
d
en
t
o
f
tu
b
u
la
r
k
id
n
ey
fu
n
ct
io
n
E
ff
ec
ts
o
n
B
M
D
co
n
ti
n
u
o
u
s
E
ff
ec
ts
o
n
b
io
m
ar
k
er
s
o
f
b
o
n
e
re
so
rp
ti
o
n
(U
H
P
,
U
L
P
)
E
ff
ec
t
si
ze
s
as
so
ci
at
ed
w
it
h
a
d
o
u
b
li
n
g
o
f
U
C
d
ex
p
o
su
re
w
er
e
?
8
.4
%
fo
r
U
H
P
,
?
6
.9
%
fo
r
U
L
P
,
0
.7
7
m
m
o
l/
d
ay
fo
r
u
ri
n
ar
y
ca
lc
iu
m
,
-
0
.0
0
9
g
/c
m
2
fo
r
p
ro
x
im
al
fo
re
ar
m
B
M
D
E
ff
ec
ts
in
d
ep
en
d
en
t
o
f
tu
b
u
la
r
k
id
n
ey
fu
n
ct
io
n
C
o
n
ti
n
u
o
u
s
ef
fe
ct
s
in
b
o
th
p
re
-
an
d
p
o
st
m
en
o
p
au
sa
l
w
o
m
en
.
S
tr
o
n
g
er
ef
fe
ct
s
o
b
se
rv
ed
in
p
o
st
m
en
o
p
au
sa
l
w
o
m
en
M
ea
n
U
C
d
le
v
el
1
1
n
m
o
l/
l
(*
1
.2
l
g
C
d
/g
cr
t)
N
aw
ro
t
et
al
.
(2
0
1
0
)
O
cc
u
p
at
io
n
al
ly
ex
p
o
se
d
y
o
u
n
g
m
en
(n
=
8
3
),
m
ea
n
ag
e
4
5
y
ea
rs
.
C
ro
ss
-s
ec
ti
o
n
al
B
M
D
,
o
st
eo
p
o
ro
si
s
(T
-
sc
o
re
\
2
.5
)*
d
efi
n
ed
in
th
re
e
b
o
n
e
si
te
s
(f
o
re
ar
m
,
h
ip
an
d
lu
m
b
ar
sp
in
e)
C
o
m
p
ar
ed
w
it
h
th
e
lo
w
es
t
(0
.5
l
g
U
C
d
/g
cr
t)
te
rt
il
e
o
f
U
C
d
,
th
e
o
d
d
s
w
er
e
4
.8
-
an
d
9
.9
-f
o
ld
h
ig
h
er
in
th
e
m
id
d
le
(0
.5
–
1
.9
lg
U
C
d
/g
cr
t)
an
d
h
ig
h
es
t
te
rt
il
e
([
1
.9
lg
C
d
/g
cr
t
in
u
ri
n
e)
E
ff
ec
ts
in
d
ep
en
d
en
t
o
f
tu
b
u
la
r
k
id
n
ey
fu
n
ct
io
n
L
o
w
es
t
ef
fe
ct
s
o
b
se
rv
ed
b
et
w
ee
n
0
.5
an
d
1
.9
lg
C
d
/g
cr
t
in
u
ri
n
e
B
M
D
b
o
n
e-
m
in
er
al
d
en
si
ty
,
U
C
d
u
ri
n
ar
y
ca
d
m
iu
m
,
cr
t
cr
ea
ti
n
in
e,
U
H
P
h
y
d
ro
x
y
ly
sy
lp
y
ri
d
in
o
li
n
e,
U
L
P
ly
sy
lp
y
ri
d
in
o
li
n
e
*
O
st
eo
p
o
ro
si
s
w
as
d
efi
n
ed
as
a
T
-s
co
re
o
r
Z
-s
co
re
to
d
efi
n
e
ag
e-
an
d
g
en
d
er
-s
p
ec
ifi
c
th
re
sh
o
ld
772 Biometals (2010) 23:769–782
123
Cadmium was negatively associated with bone min-
eral density in postmenopausal women. A 2-fold
increase in urinary Cd excretion at baseline was
associated with 73% increased risk of fractures in
women [95% confidence interval (CI) 1.16–2.57].
The corresponding results for men were 1.20 (0.75–
1.93) (Staessen et al. 1999). Data from Sweden
showed a doubling of the risk for osteoporosis for
urinary Cd levels of 0.5–3 lg Cd/g creatinine (middle
tertile) compared with the lowest tertile (\0.5 lg Cd/g)
(Alfve´n et al. 2000). In addition, an increased risk of
fractures was also noted in the Swedish Oscar study,
demonstrating an elevated hazard ratio already at
exposure levels of 2–4 lg/g creatinine (Alfve´n et al.
2004). Studies in China have reported that osteopo-
rosis is related to kidney dysfunction, especially to
tubular damage and its severity (Wang et al. 2003; Jin
et al. 2004). Although women are believed to be more
susceptible than men, a study in middle-aged men
(mean age 45 years) exposed to Cd in an occupa-
tional setting showed a dose-dependent increase of
osteoporosis. This is the first study that assessed the
bone mineral density at three sites on the skeleton
including forearm, lumbar spine and hip. Osteoporo-
sis was defined according to T-score less than -2.5
(in this case\0.56 g/cm2) in one of the measured
bone sites. Compared with the lowest tertile of
urinary Cd, the risks were 4.8- and 9.9-fold higher
in the middle (0.51–1.88 lg/g creatinine) and highest
tertile ([1.88 lg/g creatinine), respectively. Only
four (5%) men in this population had evidence of
renal tubular dysfunction (b2-microglobuline
[300 lg/g creatinine) (Nawrot et al. 2010).
A study using data from National Health and
Nutrition Examination Surveys (NHANES) reported
an increased risk for hip osteoporosis in 3,207 women
aged 50 years and older [OR = 1.43 (95% CI 1.03–
2.0)] at urinary Cd levels between 0.50 and 1.00 lg/g
creatinine as compared with the reference (\0.5 lg/g
creatinine) (Gallagher et al. 2008). Dose–response
relationships were reported on urinary Cd as a
continuous variable expressed in lg per g creatinine
[OR = 1.15 (95%CI 1.00–1.33)]. Recent data provide
more insight into the mechanisms supporting a direct
osteotoxic effect of Cd independent of the status of
kidney function in that urinary excretion of pyridinium
crosslinks from bone collagen is increased (Schutte
et al. 2008b). The shape of this association was linear
with effects observed at low levels (Table 1). The
Cd-induced bone effect is not mediated via impaired
activation of vitamin D (Engstrom et al. 2009).
Kidney
Microproteins in urine are sensitive biomarkers of
Cd-induced renal damage reflecting a tubulotoxic
effect. Among them b2 microglobulin, a small plasma
protein, which passes the glomerular filter and subse-
quently almost completely reabsorbed in the renal
tubules if no Cd-induced damage is present. Depend-
ing on the biomarker of nephrotoxicity thresholds of
urinary Cd can range from about 2 lg/g creatinine for
the onset of early biochemical alterations (e.g. hyper-
calciuria) to 10 lg/g creatinine for the development of
the classic tubular microproteinuria (Roels et al.
1999). A cross-sectional analysis of 14,778 subjects
(NHANES) showed that subjects in the highest
quartile of blood Cd ([0.6 lg/l) were almost two
times more likely to exhibit albuminuria (C30 mg/g
creatinine) and 32% more likely to have reduced
glomerular filtration rate (\60 ml/min/1.73 m2)
(Navas-Acien et al. 2009).
Epidemiological evidence shows higher suscepti-
bility for persons with diabetes to develop Cd-
induced renal dysfunction. A study of 122 men and
women aged 18–85 exposed to Cd by consuming
seafood (coast of Australia) found a statistically
significant correlation between urinary Cd levels and
albuminuria in individuals with type II diabetes, but
found no such correlation in non-diabetic individuals
(Haswell-Elkins et al. 2008). In 820 Swedish women
between the ages of 53 and 64, multiple linear
regression analysis showed statistically significant
associations between urinary a1-microglobulin and
urinary Cd with significant effect-modification for
diabetes (A˚kesson et al. 2005).
Although there is strong evidence that elevated
levels of tubular biomarkers of renal dysfunction are
associated with urinary cadmium, a surrogate of the
Cd body burden, there is less agreement about the
clinical significance and predictivity of these
changes. Prospective epidemiological evidence from
Belgium (Nawrot et al. 2008) and U.S. (Menke et al.
2009) suggests that the increased Cd related mortality
was directly related to the toxic effects of Cd, rather
than being mediated by renal dysfunction, as sug-
gested by the Japanese studies (Nishijo et al. 2006;
Arisawa et al. 2007).
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Diabetes
The Third National Health and Nutrition Examination
Survey (NHANES III), which examined 8,722 U.S.
citizens over age 40, revealed a significant association
between elevations in urinary Cd levels and increases
in fasting blood glucose levels (110–126 mg/dl)
(Schwartz et al. 2003). To exclude the effect of tubular
kidney function (defined as urine albumin, B30 lg/
ml), the investigators restricted the analysis to persons
without evidence of renal damage, but this restriction
revealed the same conclusions. However, until now
prospective evidence linking Cd exposure with higher
prevalence of diabetes is lacking. Persons with diabe-
tes appear to be more susceptible for the Cd-induced
renal effects (see paragraph on kidney).
Cancer
Three lines of evidence explain why the International
Agency for the Research on Cancer classified Cd as a
human carcinogen. First, as reviewed by Verougstra-
ete et al. (2003) several (Kazantzis et al. 1992;
Sorahan and Lancashire 1997; Ja¨rup et al. 1998b;
Sorahan and Waterhouse 1983) albeit not all studies
(Sorahan et al. 1995) in workers showed a positive
association between the risk of lung cancer and
occupational exposure to Cd. Figure 1 summarizes
the findings of these five largest occupational cohort
studies. The combined estimate showed an increased
risk of 20% in workers exposed to Cd compared with
those not exposed (Verougstraete et al. 2003).
Second, data from rats showed that the pulmonary
system is a target site for carcinogenesis after Cd
inhalation. However, exposure to toxic metals in
animal studies has usually been much higher than
those reported in humans environmentally exposed to
toxic metals. Third, several in vitro studies have
shown plausible toxicodynamic pathways, such as
increased oxidative stress (as reviewed in this special
issue by Cuypers et al. 2010), modified activity of
transcription factors (Watkin et al. 2003), and inhi-
bition of DNA repair (Jin et al. 2003). Most errors
that arise during DNA replication can be corrected by
DNA polymerase proof reading or by postreplication
mismatch repair. As reviewed in this special issue
by Hartwig (2010), inactivation of the DNA repair
machinery is an important primary effect, because
repair systems are required to deal with the constant
DNA damage associated with normal cell function.
The latter mechanism might indeed be relevant for
environmental exposure because Jin et al. (2003)
found that chronic exposure of yeast to environmen-
tally relevant concentrations of Cd can result in
extreme hypermutability. In this study, the DNA-
mismatch repair system was already inhibited by 28%
at Cd concentrations as low as 5 lM. For example,
the prostate of healthy unexposed humans accumu-
lates Cd to concentrations of 12–28 lM and human
lungs of nonsmokers accumulate Cd to concentra-
tions of 0.9–6 lM (Jin et al. 2003). Further, in vitro
studies provide evidence that Cd may act like an
estrogen (Byrne et al. 2009), forming high-affinity
complexes with estrogen receptors, suggesting a
positive role in breast cancer carcinogenesis.
Along with this experimental evidence, recent
epidemiological studies (A˚kesson et al. 2008; Kellen
et al. 2007; Kriegel et al. 2006; McElroy et al. 2006;
Nawrot et al. 2006; van Wijngaarden et al. 2008;
Vinceti et al. 2007), summarized in Table 2, gave
important positive input into the discussion on the
role of exposure to Cd in the development of cancer
in humans. First, the results of a population-based
case–control study noticed a significant 2-fold
increased risk of breast cancer in women in the
highest quartile of Cd exposure compared with those
in the lowest quartile (McElroy et al. 2006). In a
population based prospective cohort study with a
median follow-up of 17.2 years in an area close to
three zinc smelters, the association between incident
lung cancer and urinary Cd was assessed (Nawrot
et al. 2006). Cd concentration in soil ranged from 0.8
to 17.0 mg/kg. At baseline, geometric mean urinary
Cd excretion was 12.3 nmol/day (1.78 lg/day) for
people in the high-exposure area, compared with
7.7 nmol/day (0.87 lg/day) for those in the reference
(low exposure) area. The risk of lung cancer was 3.58
higher in the high exposure area compared to the area
with low exposure. As already mentioned above, 24-h
urinary excretion is a biomarker of lifetime exposure
to Cd. The risk for lung cancer was increased by 70%
for a doubling of 24-h urinary Cd excretion.
Confounding by co-exposure to arsenic was unlikely.
Epidemiological studies did not convincingly
imply Cd as a cause of prostate cancer. Of 11 cohort
studies, only three found a positive association
(Verougstraete et al. 2003). However, a recent
case–control study (Vinceti et al. 2007) with 40
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cases and 58 controls showed an excess cancer risk in
subjects in the third and fourth (highest) quartiles
(above 0.0145 lg Cd/g) of toenail Cd concentration
[OR = 1.3 (95% CI 0.3–4.9)] and 4.7 [(95% CI 1.3–
17.5), respectively, P trend = 0.004] compared with
subjects in the bottom quartile. A study (van
Wijngaarden et al. 2008) reported an association
between serum levels of Prostate Specific Antigen
(PSA) and Cd exposure. They found effect-modifi-
cation by zinc on the urinary Cd and PSA association
in the NHANES population sample including 1,320
men. An increase in urinary Cd by 1 lg/g creatinine
was associated with a 35% increase in PSA levels, in
subjects with a zinc intake below the median
(12.7 mg/day). In a case–control study, pancreatic
cancer was associated with serum Cd levels (Kriegel
et al. 2006). For each 1 lg Cd per l serum increase,
the odds for pancreatic cancer increased with 12%
(Table 3). A˚kesson et al. (2008) reported an odds
ratio of 2.9 for endometrial cancer among women
with Cd intake above highest tertile. In a study of
bladder cancer, Kellen et al. (2007) showed a 5.7-fold
50 100 150 200 250 300
Fig. 1 Standardized
mortality rates and 95% CI
for lung cancer for the five
largest occupational cohort
studies. Combined estimate
denotes a meta-analysis of
the five large cohort studies
mentioned. Figure based on
Verougstraete et al. (2003)
(with permission)
Table 2 Studies on cancer in association with environmental cadmium exposure
Site Reference Population Effect size Shape of the
association
Breast McElroy et al.
(2006)
Case–control study: n = 254
cases, n = 246 controls,
United States, based on
NHANES sample
Odds ratio: 2.29 (95% CI 1.3–4.2)
comparing the highest quartile of urinary
Cd (C0.58 lg/g crt) to the lowest
(\0.26 lg/g crt)
Continuous linear
increase in risk
Endometrium A˚kesson et al.
(2008)
Cohort study: 30,210 post
menopausal women, 16 years
follow-up, Sweden
Relative risk: 1.39 (95% CI 1.04–1.86) for
highest tertile of intake of Cd C16 lg Cd/
day versus\13.7 lg Cd/day (lowest
tertile)
Third tertile
significantly
different from
first. Shape linear
Lung caner Nawrot et al.
(2006)
Cohort study: n = 994, 15 years
follow-up, Belgium
Relative risk 1.31 (95% CI 1.03–1.65) for
doubling in urinary Cd
Continuous linear
increase in risk
Pancreas Kriegel et al.
(2006)
Case–control study: n = 31
cases, n = 52 controls, Egypt
Odds ratio 1.12 (95% CI 1.04–1.23) per lg/l
serum Cd.
Continuous
increase risk
Prostate Vinceti et al.
(2007)
Case–control study: n = 45
cases, n = 58 controls, Italy
Odds ratio: 4.7 (95% CI 1.3–17.5) for
highest quintile toenail Cd (C0.031 lg/g)
versus\0.007
Threshold observed
*0.015 lg/g
toenail Cd
Van
Wijngaarden
et al. (2008)
Cross-sectional: 320 men,
NHANES population sample,
United States
Significant Cd–zinc interaction: Men with
zinc intake\12.7 mg/day a urinary Cd
increase of 1 lg/g crt is associated with a
35% increase in serum PSA
Effect size depends
on zinc intake
Urinary
bladder
Kellen et al.
(2007)
Case–control study: n = 172
bladder cases, n = 359
controls, Belgium
Odds ratio: 5.7 (95% CI 5.0–13.8)
comparing the highest (C1 lg/l) to the
lowest tertile (\0.2 lg/l) of blood Cd
Continuous linear
increase in risk
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increase in risk between subjects with blood Cd at the
lowest tertile (\0.2 lg/l) versus the highest tertile
(C1 lg/l).
Blood pressure and effects on arteries
Chronic exposure to Cd not only leads to its
accumulation in the kidneys and liver but also in
the endothelium and vascular smooth muscle cells
(Messner and Bernhard 2010; Messner et al. 2009).
Cd and Pb at exposure levels encountered at the
workplace or in the environment are suspected to
increase blood pressure and to cause hypertension
(Nawrot et al. 2008). However, the influence of Cd on
the cardiovascular system remains controversial.
Cross-sectional and prospective studies by Staessen
et al. (2000) showed that conventional or 24-h
ambulatory blood pressure, or the risk of hyperten-
sion or cardiovascular diseases risk (Nawrot et al.
2008) in environmentally exposed populations were
not associated with 24-h urinary Cd. Subjects with
Itai-Itai disease also failed to develop hypertension
(Nakagawa and Nishijo 1996). A recent report of
NHANES showed a lower odds ratio for hypertension
in the highest urinary Cd quartile compared with the
lowest (Tellez-Plaza et al. 2008). Kurihara et al.
(2004) studied urinary Cd normalised for creatinine
as a biomarker of exposure and reported a significant
odds ratio for hypertension less than unity in both
men [0.62 (95% CI 0.42–0.92)] and women [0.67
(95% CI 0.48–0.94)]. In contrast to these negative
findings, Satarug et al. (2005) reported a positive
association between blood pressure and urinary Cd in
a population sample of 200 subjects that also showed
tubular dysfunction. The association between blood
pressure and cardiovascular risk is continuous with-
out a threshold (Nawrot et al. 2003). Therefore, blood
pressure should be treated as a continuous variable in
epidemiological research rather than as arbitrary
thresholds reflecting hypertension. Nevertheless, both
at a continuous or a dichotomous (hypertension) scale
there is no clear evidence for ‘‘pressor’’ effect due to
environmentally Cd exposure.
Recently, NHANES data linked Cd with cardio-
vascular outcomes and peripheral arterial disease.
Navas-Acien et al. (2004, 2005) reported that periph-
eral arterial diseasemight be associated with blood and
urinary Cd, thus suggesting that Cd is involved in
arterial dysfunction. The authors used the ankle-
brachial index to reflect peripheral arterial disease.
This non-invasive measure is useful in assessing the
patency of the leg arteries and predicts cardiovascular
morbidity and mortality (Resnick et al. 2004). After
accounting for traditional cardiovascular risk factors,
the odds ratio of peripheral arterial disease showed
significant increase in the odds 2.82 (95% CI 1.36–
5.85) for the highest blood Cd quartile ([6.23 nmol/l
or 0.70 lg/l) compared with the lowest quartile
(B3.56 nmol/l or 0.40 lg/l) (Navas-Acien et al.
Table 3 Selected studies on internal cadmium concentration in association with iron status
Author Population N Iron indicator Associations
Berglund et al.
(1994)
Non-Smoking women,
Sweden, 20–50 years
Women 57 Log S-Ferritin Log BCd r = -0.52, P\ 0.01
Olsson et al.
(2002)
Men and women on farms
in Sweden
Female Never-
Smokers 38
S-Ferritin BCd r = -0.52 exponential association
Muneko Nishijo
et al. (2004)
Pregnant Japanese women
30–32 years
Women 50 Iron-Intake (mg) BCd spearman r = -0.35, P\ 0.05
UCd spearman r = -0.28, ns
A˚kesson et al.
(2002)
Early pregnant women
gestational week 11
20–45 years, Sweden
Women: 210 S-Ferritin BCd spearman r = -0.23, P B 0.01
Women 188 UCd spearman r = -0.02 ns
Nawrot et al.
(2008)
Men and women in high and
low exposure area, Belgium
Men and women 711 Log S-Ferritin Log BCd regression coefficient =
-0.110 ± 0.024, P B 0.001
Kippler et al.
(2009)
Pregnant Bangladeshi women
in gestational week 14
14–44 years
Women 408 S-Ferritin Ery Cd spearman r = -0.17, P\ 0.001
BCd blood cadmium, UCd urinary cadmium, Ery erythrocytes
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2004). This epidemiologic association is in line with
data of the Atherosclerosis Risk Factors in Female
Youngsters (ARFY) study, where blood Cd level was
independently associated with early atherosclerotic
vessel wall thickening [intima-media thickness
exceeding the 90th percentile of the distribution; OR
1.6 (1.1–2.3)] (Messner et al. 2009). In contrast to these
studies the Belgian populations did not show correla-
tions between measures of arterial function and blood
Cd and failed to confirm that increased Cd body burden
(determined by 24-h urinary Cd excretion) was asso-
ciated with decreased arterial function (Schutte et al.
2008a; Plusquin et al. 2005). Aortic pulse wave
velocity, which is the gold standard of arterial stiffness,
was significantly and inversely associated with 24-h
urinary cadmium excretion (Schutte et al. 2008a).
Reproduction
No difference was found in fertility between men
occupationally exposed to Cd and an appropriately
matched control group (n = 118) by assessing birth
experiences of their wives (Gennart et al. 1992).
However, a hospital sample of the general population
with infertility problems showed that blood and
seminal Cd were significantly higher among infertility
patients than controls (median seminal plasma Cd was
0.282 lg/l in infertility patients vs. 0.092 lg/l in
controls). The percentage of motile sperm and sperm
concentration correlated inversely with seminal
plasma Cd among the infertility patients (r = -0.20,
P\ 0.04) (Benoff et al. 2009).
Prospective mortality studies
Recently, two population based cohort studies (Menke
et al. 2009; Nawrot et al. 2008) showed higher risk for
death in association with Cd exposure. The average
urinary Cd concentration at baseline was about three
times higher in the Belgian cohort (*1 lg/g creati-
nine) compared with the US cohort. The hazard ratios
(95% CI) for all-cause mortality, associated with a
2-fold higher urinary Cd were 1.28 (95% CI 1.15–
1.43) in men and 1.06 (95% CI 0.96–1.16) for women
in the US cohort (NHANES III) and 1.20 (95% CI
1.04–1.39) in the men and women combined in
the Belgian cohort. In the Belgian cohort the hazard
rates were not different between men and women (no
urinary Cd by gender interaction in relation to
mortality observed). Meta-regression of these three
hazard ratios by a random effect model revealed a 17%
(95% CI 4.1–33.2%; P\ 0.0001) increase in the
relative risk associated with a doubling of the urinary
Cd concentration. The cause-related mortality pattern
differed between the two cohorts. In the Belgian cohort
deaths from non-cardiovascular but not cardiovascular
causes increasedwith higher 24-h urinary Cd excretion
(Nawrot et al. 2008). In the NHANES study, both non-
cardiovascular and cardiovascular disease increased
with higher urinary Cd concentrations in men whereas
in women non-cardiovascular disease were border-
line significantly associated but not cardiovascular
mortality.
Previous studies in Japanese populations, showed
associations between mortality and environmental
exposure to Cd (Arisawa et al. 2007; Nishijo et al.
2006). However, there are important differences
between the Japanese observations and the recent
population based findings in the US and Belgium.
First, the median urinary Cd level in the Japanese
studies was 7.0 lg/g creatinine (Arisawa et al. 2007),
which probably explains the increased mortality from
nephritis and nephrosis (Nishijo et al. 2006). By
comparison, the median urinary Cd at baseline was
*1 lg/g creatinine in Belgium and *0.34 lg/g
creatinine (0.28 in men and 0.40 lg/g creatinine in
women) in the NHANESIII survey.
Prevention
Preventive measures that might diminish the Cd
containing dust in our homes would be to replace
carpets with floor coverings that can be cleaned with
water. One may use a vacuum cleaner with a HEPA-
filter combined with cyclone technology to remove
particles as small as 0.3 lm to prevent small
Cd-loaded particles from being remitted into the air
(Yiin et al. 2002). For most of these preventive
measures no hard scientific evidence based on
intervention studies exists. Until now, only one
intervention study has been reported (Kobayashi
et al. 2008). A study in 50 persons, with urinary
cadmium measured before and after soil replacement
of a Cd-polluted rice basin, showed 10 years after
soil replacement a decrease of 40% in urinary
cadmium excretion, but the degree of renal tubular
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injury (as reflected by b2-microglobulin, retinol
binding protein (RBP), total protein, amino-N and
glucose) did not improve.
Bioavailability of Cd in the soil and its transfer
to plants
In the general nonsmoking population, not living in a
Cd polluted area, the diet is the main source of Cd
exposure. Most foods contain low concentrations of
Cd, but high concentrations may be found in mush-
rooms, liver, kidney, and shellfish. Cereals, especially
the non-refined wheat products, rice and vegetables,
often contain elevated Cd concentrations. It seems
likely that vegetarians have an increased intake of Cd.
Plant species and varieties differ extensively in their
capacity to absorb and accumulate toxic metals.
Lettuce, spinach, celery and cabbage (leaf vegetables)
tend to accumulate relatively high concentrations of
Cd, whereas beans (and other ‘fruit vegetables’)
accumulate only low amounts of Cd. In two areas in
the North of Belgium, home grown vegetables showed
levels that exceeded the European limit (Fig. 2) with
exception of beans and other ‘fruit vegetables’. Even
in the reference area, with soil Cd levels that averaged
0.9 mg/kg soil, Cd content in about 50% of the celery
were above the EU limit. Indeed, also in the non-
polluted range (Cd levels below 1 mg Cd/kg soil) the
transfer of Cd from the soil to plants is closely related
with soil pH (Fig. 3). To know whether it is safe to
grow vegetables in polluted areas, a representative soil
sample should be taken to determine the soil Cd
concentrations. Soil pH testing is necessary to estab-
lish the ‘‘lime requirement’’ of the soil. Natural forms
of calcium carbonate are used to lime gardening and
agricultural soils. Ground lime should be applied on a
regular basis to maintain soil alkalinity, thereby
reducing Cd uptake by plants. Table 4 lists the
maximal allowable soil Cd level with respect to the
grown vegetable. On the premise that the soil pH is
high enough (pH-H2O of 7.5; pH-KCl of 6.5) it is
unlikely that vegetables grown on these specific soil
Cd levels will exceed the EU limit value for Cd.
Bioavailability of Cd in the intestine
and its transfer to blood
The amount of intestinally absorbed Cd is propor-
tional to the Cd concentration in the food. However,
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Fig. 2 Home grown vegetables from 127 households that
grew vegetables and provided samples of beans, carrots, leek
and celery. Vegetables were dried for 24 h at 60C, incinerated
at low temperature, digested with 3 mol/l hydrochloric acid
and measured for cadmium by atomic absorption spectrometry.
The geometric mean soil cadmium concentration was 5.8 times
higher in the polluted area and averaged (5th–95th percentile
interval) 0.9 mg/kg soil (0.4–1.6) in the low polluted area and
5.3 mg/kg (1.4–18.9) in the high polluted area (P\ 0.0001).
European limit values are 2 mg/kg (dry weight) for leafy
vegetables and 0.9 mg/kg for all others
Fig. 3 Cadmium concentration in carrots in relation to the
cadmium concentration and pH of the soil. Line denotes the
EU limit value of 0.9 mg/kg d.w. (dry weight). pH based on
pH-H2O
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there are factors that influence the rate of intestinal
absorption of Cd. The rate of Cd absorption is
increased if the nutritional status of calcium, iron or
zinc is low. The duodenal iron transporter is up-
regulated by iron deficiency, which leads to an
increased intestinal absorption of dietary Cd. This is
probably the main reason why the body burden of
Cd is generally higher among women (Menke et al.
2009; Vahter et al. 2007) whose prevalence of iron
depletion is higher than that of men. Urinary
Cd increases longitudinally among pregnant women
with exhausted iron stores (soluble transferrin
receptor—serum ferritin ratio above 500) (A˚kesson
et al. 2002). The increase in urinary Cd with age is
more pronounced in multiparous than in nullparous
women (A˚kesson et al. 2002). Table 3 lists recent
studies linking iron status with blood and urine Cd.
Most of the studies (A˚kesson et al. 2002; Berglund
et al. 1994; Kippler et al. 2009; Nawrot et al. 2008;
Nishijo et al. 2004; Olsson et al. 2002) found a
significant increase in body Cd stores in individuals
with lower iron status. In Europe, iron deficiency
is considered to be one of the main nutritional
deficiency disorders affecting large fractions of the
population, including, pre-postmenopausal and preg-
nant women. About 20% of young women have iron
deficiency (serum ferritin\15 lg/l) (Grondin et al.
2008).
Conclusions
There has been substantial progress in the evaluation
of the health effects of Cd and in the exploration of the
shape of the concentration-response function at dif-
ferent organ systems. These results have important
scientific, medical, and public health implications. To
significantly reduce the adverse health effects of
exposure to a toxic metal like Cd, the heart of the
matter remains that further efforts must be made to
reduce Cd pollution by appropriate legislation and its
enforcement. However, in historically polluted areas,
specific preventive strategies including covering of the
polluted soil and restrictions to gardening and agri-
culture activities might be crucial depending on
the concentrations and soil characteristics. The mean
exposure for adults across Europe is close to the
tolerable weekly intake of 2.5 lg/kg body weight.
Subgroups such as vegetarians, children, smokers and
people living in highly contaminated areasmay exceed
the tolerable weekly intake about 2-fold. To diminish
the transfer of Cd from soil to plants, the soil Cd
bioavailability should be reduced by maintaining
agricultural and garden soil pH close to neutral.
Balanced iron intake is effective in reducing the
bioavailability of Cd present in the intestine, by
reducing its absorption. Along with the recent knowl-
edge concerning low dose Cd exposure, the current
exposure to Cd at the population level should be kept
as low as possible so that the urinary Cd concentration
is kept below 0.66 lg/g creatinine (margin of
safety = 3) as proposed by the EU(European Com-
munity report, EUR 23424 EN). The relations we
discussed here between internal Cd dose andmorbidity
and mortality are based on individual data and satisfy
Hill’s criteria for causality (Hill 1965).
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